Related Experiment Videos
Hyperparathyroidism after radioactive iodine therapy for Graves disease
Surgery
|November 1, 1982
Summary
Radioactive iodine treatment for Graves disease may increase the risk of developing hyperparathyroidism, particularly in younger patients. Regular calcium level monitoring is recommended for those treated with radioactive iodine.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Oncology
Background:
- External ionizing radiation exposure, particularly to the head and neck, is linked to parathyroid gland dysfunction.
- Graves disease is commonly treated with radioactive iodine (RAI), but its association with secondary hyperparathyroidism is not well-documented.
Observation:
- This study reports on four patients who developed hyperparathyroidism after RAI treatment for Graves disease.
- Operative findings revealed parathyroid adenomas in three patients and hyperplasia in one.
- Previous research noted elevated calcium levels in children and adolescents treated with RAI for Graves disease.
Findings:
- Hyperparathyroidism requiring surgery occurred in patients previously treated with RAI for Graves disease.
- Pathological examination showed parathyroid adenoma or hyperplasia in all cases.
- The incidence of hyperparathyroidism appears higher in pediatric patients treated with RAI for Graves disease.
Implications:
- The findings suggest a potential increased risk of hyperparathyroidism following RAI treatment for Graves disease, especially in younger populations.
- Routine monitoring of serum calcium levels every five years is advisable for patients treated with RAI for hyperthyroidism.
- Further research is needed to determine if adults treated with RAI for Graves disease have a similar increased risk.